- Vitamin C through upregulating SYNPO2 level suppresses the proliferation and migration of glioma cells. [Journal Article]J BUON. 2021 Nov 01; 26. [Online ahead of print]JB
- CONCLUSIONS: VC blocks glioma cells to proliferate and migrate by upregulating SYNPO2.
- Some concerns about clinical-pathological characteristics of breast cancer cases detected by chest computed tomography. [Letter]J BUON. 2021 Sep-Oct; 26(5):2208.JB
- SARS-CoV-2 infection in breast carcinoma patients. [Journal Article]J BUON. 2021 Sep-Oct; 26(5):2207-2208.JB
- Taxane use for breast cancer-related lymphoedema risk. [Letter]J BUON. 2021 Sep-Oct; 26(5):2206.JB
- The place of Omalizumab in the treatment of Carboplatin hypersensitivity. [Letter]J BUON. 2021 Sep-Oct; 26(5):2205.JB
- Association between breast cancer risk factors and tumor subtypes. [Letter]J BUON. 2021 Sep-Oct; 26(5):2204-2205.JB
- Is there any association between human papillomavirus amplification and ductal histology in invasive breast carcinoma? [Letter]J BUON. 2021 Sep-Oct; 26(5):2204.JB
- Vismodegib and radiotherapy combination in treatment of cancer. [Letter]J BUON. 2021 Sep-Oct; 26(5):2203-2204.JB
- Association between aspirin use and reduction in risk of triple negative breast cancer: Still debatable issue? [Letter]J BUON. 2021 Sep-Oct; 26(5):2202-2203.JB
- Is early change in systemic inflammatory markers associated with treatment response in patients who received pazopanib? [Journal Article]
- CONCLUSIONS: Early decline in serum CRP, neutrophil and NLR levels in RCC patients who received pazopanib at the first month was significantly associated with disease control, assuming a predictive role for the first radiological assessment. However, there was no significant association between change in serum inflammatory marker levels and disease control in STS patients.
- Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy in the treatment of rare tumors with peritoneal metastases. [Journal Article]J BUON. 2021 Sep-Oct; 26(5):2191-2195.JB
- CONCLUSIONS: CRS followed by HIPEC is an effective and safe method in the treatment of rare tumors with PM. Further large, well-designed prospective studies are needed to validate these results.
- COVID-19 vaccines and cancer patients: acceptance, attitudes and safety. [Journal Article]
- CONCLUSIONS: We have confirmed that patients are reluctant of receiving vaccine due to fear of side effects, especially during the active cancer treatment. However, real-world evidence and clinical trials data have gathered enough evidence to reassure any doubts of the patients and their oncologists on safety and efficacy of anti SARS-COV2 vaccines.
- Assessment of oncology patients' satisfaction from intravenous chemotherapy. [Journal Article]
- CONCLUSIONS: Generally, chemotherapy meets patients' expectations with cancer. Symptoms such as fatigue, anxiety, pain, and nausea affect their satisfaction. Treatment's satisfaction can be improved by evaluating symptoms, which will lead to appropriate interventions.